Stockholders Approve Reverse Split and Double Authorized Shares

summarizeSummary

Equillium shareholders approved a reverse stock split and doubled the authorized common stock, setting the stage for potential significant future dilution and capital raises.

check_boxKey Events · Corporate Governance and Compliance · EQ

• Reverse Stock Split Approved

  Stockholders approved an amendment to effect a reverse stock split of the company's common stock at a ratio in the range of 1-for-2 to 1-for-20, at the Board's discretion. This follows the proposal in the DEF 14A filed on 2026-04-15.

• Authorized Shares Doubled

  The number of authorized common shares was increased from 200,000,000 to 400,000,000 shares. This provides the company with the ability to issue an additional 200,000,000 shares, representing a potential dilution of over 300% based on current outstanding shares.

• Board Size Reduced

  Former director Peter Colabuono was not renominated, and the Board of Directors was reduced from seven to six members.

auto_awesomeAnalysis · EQ · Life Sciences

Equillium's stockholders approved two critical proposals: a reverse stock split (1-for-2 to 1-for-20) and an increase in authorized common stock from 200 million to 400 million shares. The increase in authorized shares provides the company with significant capacity for future equity financing, representing a potential dilution of over 300% if all newly authorized shares were issued. The reverse split is often a precursor to maintaining listing requirements or facilitating further capital raises, indicating a strategic move to address the company's stock price and capital structure.